150 related articles for article (PubMed ID: 8822942)
1. Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein.
Urashima M; Ogata A; Chauhan D; Vidriales MB; Teoh G; Hoshi Y; Schlossman RL; DeCaprio JA; Anderson KC
Blood; 1996 Sep; 88(6):2219-27. PubMed ID: 8822942
[TBL] [Abstract][Full Text] [Related]
2. p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon.
Thomas NS; Pizzey AR; Tiwari S; Williams CD; Yang J
J Biol Chem; 1998 Sep; 273(37):23659-67. PubMed ID: 9726970
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells.
Urashima M; Ogata A; Chauhan D; Hatziyanni M; Vidriales MB; Dedera DA; Schlossman RL; Anderson KC
Blood; 1996 Mar; 87(5):1928-38. PubMed ID: 8634441
[TBL] [Abstract][Full Text] [Related]
4. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
6. Role of CDK4 and p16INK4A in interleukin-6-mediated growth of multiple myeloma.
Urashima M; Teoh G; Ogata A; Chauhan D; Treon SP; Hoshi Y; DeCaprio JA; Anderson KC
Leukemia; 1997 Nov; 11(11):1957-63. PubMed ID: 9369432
[TBL] [Abstract][Full Text] [Related]
7. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
Mann DJ; Jones NC
Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
[TBL] [Abstract][Full Text] [Related]
8. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
Ahmad N; Gupta S; Mukhtar H
Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an E2F-p130 complex formed during growth arrest.
Corbeil HB; Branton PE
Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
[TBL] [Abstract][Full Text] [Related]
10. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698
[TBL] [Abstract][Full Text] [Related]
11. Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.
Melamed D; Tiefenbrun N; Yarden A; Kimchi A
Mol Cell Biol; 1993 Sep; 13(9):5255-65. PubMed ID: 7689148
[TBL] [Abstract][Full Text] [Related]
12. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
[TBL] [Abstract][Full Text] [Related]
13. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.
Sellers WR; Novitch BG; Miyake S; Heith A; Otterson GA; Kaye FJ; Lassar AB; Kaelin WG
Genes Dev; 1998 Jan; 12(1):95-106. PubMed ID: 9420334
[TBL] [Abstract][Full Text] [Related]
14. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
Rampalli AM; Gao CY; Chauthaiwale VM; Zelenka PS
Oncogene; 1998 Jan; 16(3):399-408. PubMed ID: 9467965
[TBL] [Abstract][Full Text] [Related]
15. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 induces growth arrest by hypophosphorylation of the retinoblastoma susceptibility gene product RB.
Muthukkumar S; Sells SF; Crist SA; Rangnekar VM
J Biol Chem; 1996 Mar; 271(10):5733-40. PubMed ID: 8621439
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis.
Yamamoto H; Soh JW; Monden T; Klein MG; Zhang LM; Shirin H; Arber N; Tomita N; Schieren I; Stein CA; Weinstein IB
Clin Cancer Res; 1999 Jul; 5(7):1805-15. PubMed ID: 10430085
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro.
Peeper DS; Keblusek P; Helin K; Toebes M; van der Eb AJ; Zantema A
Oncogene; 1995 Jan; 10(1):39-48. PubMed ID: 7824278
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
20. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein.
Iavarone A; Garg P; Lasorella A; Hsu J; Israel MA
Genes Dev; 1994 Jun; 8(11):1270-84. PubMed ID: 7926730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
